RushNet, Inc. (RSHN)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.78 Million USD | -74.08% |
| 2022 | 6.89 Million USD | 16.99% |
| 2021 | 5.89 Million USD | 34.39% |
| 2020 | 4.38 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2023 Q3 | 1.78 Million USD | 17.69% |
| 2023 FY | 1.78 Million USD | -74.08% |
| 2023 Q1 | 621.89 Thousand USD | -40.23% |
| 2023 Q2 | 1.51 Million USD | 144.23% |
| 2022 Q3 | 2.48 Million USD | 25.67% |
| 2022 Q1 | 1.39 Million USD | 7.21% |
| 2022 FY | 6.89 Million USD | 16.99% |
| 2022 Q4 | 1.04 Million USD | -58.14% |
| 2022 Q2 | 1.97 Million USD | 42.09% |
| 2021 Q1 | 1.46 Million USD | 0.0% |
| 2021 FY | 5.89 Million USD | 34.39% |
| 2021 Q4 | 1.29 Million USD | -71.77% |
| 2021 Q3 | 4.59 Million USD | 196.32% |
| 2021 Q2 | 1.55 Million USD | 6.21% |
| 2020 FY | 4.38 Million USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -95.825% |
| Arrayit Corporation | 4.37 Million USD | 59.156% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | 93.086% |
| Bioqual, Inc. | 58.59 Million USD | 96.949% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | 88.311% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.976% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | 71.916% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -70.017% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 95.554% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -299.527% |
| InVitro International | 792.62 Thousand USD | -125.564% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | 83.938% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | 75.252% |
| NovelStem International Corp. | 12 Thousand USD | -14799.0% |
| Optigenex Inc. | 465.97 Thousand USD | -283.69% |
| PharmChem, Inc. | 6.01 Million USD | 70.263% |
| Proteome Sciences plc | 6.4 Million USD | 72.067% |
| Response Genetics, Inc | 18.04 Million USD | 90.089% |
| Rennova Health, Inc. | 13.03 Million USD | 86.285% |
| ScreenPro Security Inc. | 1.91 Million USD | 6.594% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | 52.889% |
| Todos Medical Ltd. | 7.69 Million USD | 76.766% |